These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 13760427)

  • 41. Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremia.
    Lee CC; Wang JL; Lee CH; Hung YP; Hong MY; Tang HJ; Ko WC
    Int J Antimicrob Agents; 2017 Sep; 50(3):371-376. PubMed ID: 28694235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [TRIAL TREATMENT OF VARIOUS "PROTEUS" INFECTIONS WITH 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL) PYRIMIDINE, OR (TRIM'ETHOPRIME)].
    SCHNEIDER M; SCHWARZENBERG L; CATTAN A; SCHLUMBERGER JR; AMIEL JL; MATHE G
    Presse Med (1893); 1965 Mar; 73():893-4. PubMed ID: 14259732
    [No Abstract]   [Full Text] [Related]  

  • 43. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use.
    Prentice B; Robinson BL
    Can Med Assoc J; 1979 Sep; 121(6):745-9. PubMed ID: 519613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fatal septicemia due to Providence group bacilli.
    Milstoc M; Steinberg P
    J Am Geriatr Soc; 1973 Apr; 21(4):159-63. PubMed ID: 4728663
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapy of gram positive bacteremias with presentation of four cases.
    BECKWITH RR; GOYETTE EM; SPICER WS; GRABER CD
    Circulation; 1954 Jul; 10(1):56-64. PubMed ID: 13172861
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antibiotic therapy of severe Proteus mirabilis infections].
    RENE-MARTIN ; SUREAU B; BERROD J; de PRAINGY
    Cah Rmf Bull Med Guide Pract Rev; 1962 Dec; 76():713-20. PubMed ID: 13981655
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chemotherapy of septicemia and endocarditis].
    Stille W
    Z Gesamte Inn Med; 1977 Aug; 32(15):Suppl: 225-30. PubMed ID: 335685
    [No Abstract]   [Full Text] [Related]  

  • 48. BACTEREMIA: MICROBES, MANIFESTATIONS, AND METHODS OF MANAGEMENT. I. COCCAL INFECTIONS.
    MARTIN WJ
    Minn Med; 1964 Sep; 47():1105-10. PubMed ID: 14244834
    [No Abstract]   [Full Text] [Related]  

  • 49. [Specific immune preparations for the prevention and treatment of suppurative-inflammatory diseases of Proteus etiology (a review of the literature)].
    Nazarchuk LV
    Lik Sprava; 1992 Jun; (6):28-34. PubMed ID: 1280887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical trial with triclobisonium chloride in the treatment of B. proteus ear infections. A preliminary report.
    GOROSIN R; BLANCHARD C
    Laryngoscope; 1961 Jan; 71():78-81. PubMed ID: 13707309
    [No Abstract]   [Full Text] [Related]  

  • 51. [The treatment of Proteus infections of the urinary tract with Lactobacillus acidolphus].
    TOMIC K; KAROVIC K; KRIVEC O; KOVACEVIC M
    Acta Chir Iugosl; 1955; 2(2-3):212-9. PubMed ID: 13301276
    [No Abstract]   [Full Text] [Related]  

  • 52. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.
    Tsai HY; Chen YH; Tang HJ; Huang CC; Liao CH; Chu FY; Chuang YC; Sheng WH; Ko WC; Hsueh PR
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):222-6. PubMed ID: 25139843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacteremia owing to Proteus organisms; a method of treatment.
    SPITTEL JA; MARTIN WJ; GERACI JE; NICHOLS DR
    Proc Staff Meet Mayo Clin; 1954 Apr; 29(8):225-8. PubMed ID: 13155610
    [No Abstract]   [Full Text] [Related]  

  • 54. Proteus bacteraemia in a general hospital 1972-1982.
    Berger SA
    J Hosp Infect; 1985 Sep; 6(3):293-8. PubMed ID: 2865295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neonatal septicemia after circumcision.
    Kirkpatrick BV; Eitzman DV
    Clin Pediatr (Phila); 1974 Sep; 13(9):767-8. PubMed ID: 4414788
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter: Therapeutic use of peritoneal cells.
    Fakhri O; Al-Mondhiry H; Rifaat UN; Khalil MA
    Lancet; 1976 Jun; 1(7971):1244-5. PubMed ID: 58290
    [No Abstract]   [Full Text] [Related]  

  • 57. Correlation between results of the tube dilution method for determining bacterial sensitivity to antibiotics and the results of the administration of these antibiotics to patients with staphylococcic bacteremia.
    ABBOUD FM; WAISBREN BA
    Antibiot Annu; 1958-1959; 6():748-56. PubMed ID: 13637830
    [No Abstract]   [Full Text] [Related]  

  • 58. Proteus infections succesfully treated in general practice with bicillin and streptomycin.
    PELKOWITZ D
    S Afr Med J; 1959 Mar; 33(13):267-8. PubMed ID: 13646881
    [No Abstract]   [Full Text] [Related]  

  • 59. Pan-susceptible Proteus mirabilis septicemia in a patient multicolonized by pan-resistant bacteria.
    Salomon J; Dinh A; Lawrence C; Ronco E; Herrmann JL; Bernard L
    Med Mal Infect; 2011 May; 41(5):262-3. PubMed ID: 21193275
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.